Department of General Surgery, Shanghai Key Laboratory of Gastric Neoplasms, Shanghai Institute of Digestive Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
Int J Biol Sci. 2021 Apr 12;17(7):1629-1643. doi: 10.7150/ijbs.58921. eCollection 2021.
Long non-coding RNA (lncRNA) small nucleolar RNA host gene 12 (SNHG12) plays important roles in the pathogenesis and progression of cancers. However, the role of SNHG12 in the metastasis of gastric cancer (GC) has not yet been thoroughly investigated. In the present study, we demonstrated that SNHG12 was upregulated in GC tissues and cell lines. In addition, the expression level of SNHG12 in GC samples was significantly related to tumor invasion depth, TNM stage and lymph node metastasis and was associated with disease-free survival (DFS) and overall survival (OS) in GC patients. and assays indicated that SNHG12 promotes GC metastasis and epithelial-mesenchymal transition (EMT). Bioinformatics and mechanistic analyses revealed that SNHG12 can directly target miR-218-5p to regulate YWHAZ mRNA, forming an SNHG12/miR-218-5p/YWHAZ axis and decreasing the ubiquitination of β-catenin. In addition, SNHG12 stabilizes CTNNB1 mRNA by binding with HuR, thus activating the β-catenin signaling pathway. Further analysis also revealed that the transcription factor YY1 negatively modulates SNHG12 transcription. In conclusion, SNHG12 is a potential prognostic marker and therapeutic target for GC. Negatively modulated by YY1, SNHG12 promotes GC metastasis and EMT by regulating the miR-218-5p/YWHAZ axis and stabilizing CTNNB1 via activation of the β-catenin signaling pathway.
长链非编码 RNA (lncRNA) 小核仁 RNA 宿主基因 12 (SNHG12) 在癌症的发病机制和进展中发挥重要作用。然而,SNHG12 在胃癌 (GC) 转移中的作用尚未得到彻底研究。在本研究中,我们证明 SNHG12 在 GC 组织和细胞系中上调。此外,GC 样本中 SNHG12 的表达水平与肿瘤浸润深度、TNM 分期和淋巴结转移显著相关,与 GC 患者的无病生存 (DFS) 和总生存 (OS) 相关。划痕和侵袭实验表明 SNHG12 促进 GC 转移和上皮间质转化 (EMT)。生物信息学和机制分析表明,SNHG12 可以直接靶向 miR-218-5p 调节 YWHAZ mRNA,形成 SNHG12/miR-218-5p/YWHAZ 轴,减少 β-连环蛋白的泛素化。此外,SNHG12 通过与 HuR 结合稳定 CTNNB1 mRNA,从而激活 β-连环蛋白信号通路。进一步的分析还表明转录因子 YY1 负调控 SNHG12 的转录。总之,SNHG12 是 GC 的一个潜在的预后标志物和治疗靶点。YY1 负调控 SNHG12 通过调节 miR-218-5p/YWHAZ 轴和通过激活 β-连环蛋白信号通路稳定 CTNNB1 促进 GC 转移和 EMT。